Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
158 hedge funds and large institutions have $1.02B invested in Spectrum Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 61 increasing their positions, 22 reducing their positions, and 12 closing their positions.
292% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 12
194% more call options, than puts
Call options by funds: $6.16M | Put options by funds: $2.09M
177% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 22
145% more capital invested
Capital invested by funds: $416M → $1.02B (+$603M)
27% more funds holding
Funds holding: 124 → 158 (+34)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$60.5M |
| 2 |
Primecap Management
Pasadena,
California
|
+$36.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.3M |
| 4 |
Renaissance Technologies
New York
|
+$5.32M |
| 5 |
Goldman Sachs
New York
|
+$5.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$6.95M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.65M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.39M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.68M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.17M |
SPPI Hedge Fund Activity: Q3 2017 in Review
158 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2017, worth a combined $1.02B — up 145% from $416M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new SPPI positions and 12 closed out — a net gain of 35 holders — while 61 added to existing stakes and 22 trimmed.
The largest buyer was Consonance Capital Management, adding an estimated $60.5M. The largest seller was Macquarie Group, cutting an estimated $6.95M.
- 158 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2017, up from 124 in Q2 2017.
- Funds reported $1.02B of Spectrum Pharmaceuticals Inc stock for Q3 2017, up 145% quarter-over-quarter.
- 47 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2017 and 12 closed out, a net change of +35 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2017 was Consonance Capital Management, an estimated $60.5M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2017 was Macquarie Group, an estimated $6.95M sold.
Based on aggregated 13F filings for Q3 2017.